nialamide has been researched along with kanamycin a in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Erlach, A | 1 |
Darrouzet, MJ | 1 |
CENZI, P; MEO, G | 1 |
1 review(s) available for nialamide and kanamycin a
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for nialamide and kanamycin a
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Clinical studies of cochleotoxicosis due to viomycin and kanamycin during tuberculostatic treatment (a prophylactic attempt)].
Topics: Adult; Aged; Audiometry; Cochlea; Deafness; Humans; Kanamycin; Labyrinth Diseases; Male; Nialamide; Tuberculosis; Viomycin | 1968 |
[Attempt to protect the organ of Corti against the ototoxicity of antibiotics].
Topics: Animals; Dexamethasone; Glutathione; Guinea Pigs; Kanamycin; Nialamide; Organ of Corti; Vitamin B Complex | 1967 |
[TREATMENT OF OTOTOXIC MANIFESTATIONS DUE TO ANTITUBERCULAR ANTIBIOTIC THERAPY. CLINICAL USE OF A MONOAMINE OXIDASE INHIBITOR (NIALAMIDE)].
Topics: Antibiotics, Antitubercular; Antitubercular Agents; Audiometry; Cochlear Nerve; Deafness; Dihydrostreptomycin Sulfate; Kanamycin; Monoamine Oxidase Inhibitors; Nialamide; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Vertigo; Vestibular Nerve; Viomycin | 1964 |